We are live on ! Find out more
Primecap Management

Primecap Management Portfolio holdings

AUM $127B
1-Year Est. Return 44.11%
This Fund
S&P 500
This Quarter Est. Return
+12.15%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$121B
AUM Growth
+$4.67B
Cap. Flow
-$5.12B
Cap. Flow %
-4.23%
Top 10 Hldgs %
32.97%
Holding
317
New
11
Increased
63
Reduced
194
Closed
6

Top Buys

Rank Stock Value
1
ONC
BeOne Medicines Ltd
ONC
+$380M
2
BIDU icon
Baidu
BIDU
+$159M
3
BNTX icon
BioNTech
BNTX
+$97.1M
4
XPEV icon
XPeng
XPEV
+$83.7M
5
FDX icon
FedEx
FDX
+$80.7M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$708M
2
QGEN icon
Qiagen
QGEN
+$562M
3
TSLA icon
Tesla
TSLA
+$465M
4
MSFT icon
Microsoft
MSFT
+$426M
5
QCOM icon
Qualcomm
QCOM
+$378M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 29.17%
3 Industrials 12.07%
4 Consumer Discretionary 11.43%
5 Financials 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNR
276
DELISTED
Cornerstone Building Brands, Inc.
CNR
$2.71M ﹤0.01%
340,000
MBII
277
DELISTED
Marrone Bio Innovations, Inc.
MBII
$2.48M ﹤0.01%
2,035,300
-155,000
-7% -$188K
BOOT icon
278
Boot Barn
BOOT
$4.71B
$2.39M ﹤0.01%
85,000
-32,000
-27% -$776K
HCAT icon
279
Health Catalyst
HCAT
$159M
$2.38M ﹤0.01%
64,909
+20,000
+45% +$679K
TPCO
280
DELISTED
Tribune Publishing Company Common Stock
TPCO
$2.35M ﹤0.01%
201,525
-269,400
-57% -$2.88M
OSW icon
281
OneSpaWorld
OSW
$2.76B
$2.27M ﹤0.01%
350,000
DBD
282
DELISTED
Diebold Nixdorf Incorporated
DBD
$2.25M ﹤0.01%
294,000
-1,000
-0.3% -$7.36K
SLB icon
283
SLB Ltd
SLB
$76.5B
$2.21M ﹤0.01%
141,900
+29,700
+26% +$552K
GIL icon
284
Gildan
GIL
$9.38B
$2.13M ﹤0.01%
108,340
-25,000
-19% -$462K
MGNI icon
285
Magnite
MGNI
$2.73B
$2.08M ﹤0.01%
300,000
OKTA icon
286
Okta
OKTA
$23.9B
$2.07M ﹤0.01%
9,700
+2,450
+34% +$511K
AUD
287
DELISTED
Audacy, Inc.
AUD
$1.93M ﹤0.01%
1,200,000
AXP icon
288
American Express
AXP
$226B
$1.89M ﹤0.01%
18,800
TUES
289
DELISTED
Tuesday Morning Corp
TUES
$1.79M ﹤0.01%
1,306,400
-210,600
-14% -$289K
HOME
290
DELISTED
At Home Group Inc.
HOME
$1.67M ﹤0.01%
112,100
UNH icon
291
UnitedHealth
UNH
$379B
$1.57M ﹤0.01%
5,024
+1,700
+51% +$522K
ABUS icon
292
Arbutus Biopharma
ABUS
$871M
$1.56M ﹤0.01%
500,000
PBH icon
293
Prestige Consumer Healthcare
PBH
$2.39B
$1.51M ﹤0.01%
41,400
FIVE icon
294
Five Below
FIVE
$11.5B
$1.49M ﹤0.01%
11,700
CERN
295
DELISTED
Cerner Corp
CERN
$1.4M ﹤0.01%
19,400
GEF.B icon
296
Greif Class B
GEF.B
$3.8B
$1.3M ﹤0.01%
33,000
MREO
297
Mereo BioPharma
MREO
$48.2M
$1.28M ﹤0.01%
489,100
BE icon
298
Bloom Energy
BE
$53.5B
$1.27M ﹤0.01%
70,600
NGVT icon
299
Ingevity
NGVT
$2.59B
$1.24M ﹤0.01%
25,100
+400
+2% +$22.6K
CE icon
300
Celanese
CE
$4.87B
$1.18M ﹤0.01%
10,950

Similar funds

Primecap Management's Q3 2020 Portfolio in Review

As of Q3 2020, Primecap Management held 317 positions worth $121B, up 4% from $117B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Primecap Management withdrew a net $5.12B in Q3 2020, closing 6 positions and reducing 194 holdings. Its most notable exit was Qiagen, an estimated $562M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Primecap Management opened a new position in XPeng worth $85.9M.

  • Primecap Management's largest Q3 2020 buy was XPeng: 4,278,700 shares worth $85.9M.
  • Primecap Management added most to BeOne Medicines Ltd in Q3 2020, an estimated $380M increase.
  • Primecap Management's biggest Q3 2020 reduction was Adobe, cutting an estimated $708M.
  • Primecap Management fully exited Qiagen in Q3 2020, selling an estimated $562M.
  • Primecap Management's ten largest holdings make up 33% of its $121B portfolio in Q3 2020.
  • Primecap Management opened 11 new positions and closed 6 in Q3 2020.
  • Primecap Management's portfolio value rose 4% quarter-over-quarter to $121B.

Based on Primecap Management's 13F filing for Q3 2020, filed 13 Nov 2020.